SDGR: Strong growth, platform innovation, and new products drive momentum and profitability focus
The conference highlighted advances in computational drug discovery, with strong growth in software and hosted solutions, new product launches like Bunsen and Predictive Tox, and expanding partnerships. Financial performance is robust, with a focus on operational efficiency and a clear path to prof…